News In Context

The Michael J. Fox Foundation understands that it can be challenging to gain clarity and perspective on breaking Parkinson's news. Q&As in this section are conducted with leading experts in the PD field to quickly provide an informed, impartial opinion on new findings — and get to the bottom of their implications for people with Parkinson's and for researchers.

2012

2011

2010

Descending

05/01/2012 News in Context: Weighing Different Scales: Unified Dyskinesia Rating Scale Comes out on Top, Could Speed Development of New Dyskinesia Treatments

Researchers funded by The Michael J. Fox Foundation (MJFF) have identified the best clinical scale for measuring patient response to therapies to treat dyskinesia, the debilitating, uncontrollable movements that are often a side effect of Parkinson’s disease (PD) drugs.

04/11/2012 News in Context: Commonly Used Drugs Improve Depression in People with PD

First-of-its-kind study says that drugs may ease depression without aggravating the motor symptoms of the disease.

03/21/2012 News in Context: Addex Adds It Up for Parkinson's Patients

Biotech announces positive data from clinical study of drug to treat dyskinesia

Next: Researcher Area Position Papers